Literature DB >> 23051788

SGLT2 inhibitors race to enter type-2 diabetes market.

Cormac Sheridan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23051788     DOI： 10.1038/nbt1012-899

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

Review 1.  SGLT2 inhibition--a novel strategy for diabetes treatment.

Authors:  Edward C Chao; Robert R Henry
Journal:  Nat Rev Drug Discov       Date:  2010-05-28       Impact factor: 84.694
  1 in total
  2 in total

1.  SGLT2 inhibitors enter crowded diabetes space.

Authors:  Aaron Bouchie
Journal:  Nat Biotechnol       Date:  2013-06       Impact factor: 54.908

2.  Inhibition of sodium-linked glucose reabsorption normalizes diabetes-induced glomerular hyperfiltration in conscious adenosine A₁-receptor deficient mice.

Authors:  J Sällström; T Eriksson; B B Fredholm; A E G Persson; F Palm
Journal:  Acta Physiol (Oxf)       Date:  2013-08-27       Impact factor: 6.311
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.